NVET

Nexvet

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nexvet Biopharma PLC market cap is $80.01M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Nexvet Biopharma PLC 52 week high is $6.76 as of September 28, 2025.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nexvet Biopharma PLC 52 week low is $2.75 as of September 28, 2025.

Nexvet Biopharma PLC stock price today is $6.72.

Nexvet Biopharma PLC stock price yesterday was $6.72.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nexvet Biopharma PLC’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nexvet Biopharma PLC P/B ratio is 3.8253.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Nexvet Biopharma PLC's EBITDA is N/A.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nexvet Biopharma PLC 50-day moving average is $6.68.

Nexvet Biopharma PLC has 51 employees.